Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05217160 · ClinicalTrials.gov registry record · Phase 4
Pilot Study: KeraStat® Gel for Topical Delivery of Morphine for Management of Non-Healing, Painful Open Wounds and Ulcers
A Phase 4 study of Burns and Wound of Skin, sponsored by The Metis Foundation.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT05217160 is a Phase 4 study of Burns and Wound of Skin that is actively recruiting participants, run by The Metis Foundation. The registered enrollment target is 24 participants, below the 83-participant average among 36 other Burns trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05217160, a Phase 4 study of Burns and Wound of Skin, is actively recruiting participants, sponsored by The Metis Foundation.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is intended to provide information from subjects who currently have painful, chronically open wounds and assess the pain reduction capacity of KeraStat® Gel with Morphine. In gathering data from subjects who have baseline pain from their chronically open wounds, the investigators can then evaluate the capacity of KeraStat® Gel plus Morphine in reducing the subjects daily pain levels, pain associated with dressing changes, and pain medication consumption.
Conditions Studied
Interventions
- DRUG KeraStat® Gel with Morphine application
- DRUG KeraStat® Gel application
Study Locations (1)
Texas
- South Texas Aesthetic and Reconstructive Surgery - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2021-05-11 |
| Est. Completion | 2022-05-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05217160
The ClinicalTrials.gov registry entry for NCT05217160 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 83-participant average among 36 other Burns trials with a reported enrollment target (71% lower). The listed sponsor is The Metis Foundation, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Burns appearing as the primary indexed condition, and to 2 interventions - of which KeraStat® Gel with Morphine application is the first listed.
NCT05217160 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05217160 about?
NCT05217160 is a clinical study titled "Pilot Study: KeraStat® Gel for Topical Delivery of Morphine for Management of Non-Healing, Painful Open Wounds and Ulcers". This study is intended to provide information from subjects who currently have painful, chronically open wounds and assess the pain reduction capacity of KeraStat® Gel with Morphine. In gathering data from subjects who have baseline pain from their chronically open wounds, the investigators can then...
What is the current status of trial NCT05217160?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2021-05-11. Estimated completion is 2022-05-31.
What conditions does trial NCT05217160 study?
This clinical trial studies the following conditions: Burns, Wound of Skin.
What interventions are being tested in trial NCT05217160?
The interventions under investigation include: KeraStat® Gel with Morphine application (DRUG), KeraStat® Gel application (DRUG).
Who is sponsoring clinical trial NCT05217160?
This trial is sponsored by The Metis Foundation, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05217160 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Burns
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain
RECRUITING · Phase 4
-
Burn Study- Tranexamic Acid Versus Thrombin in Split Thickness Skin Graft
RECRUITING · Phase 4
-
Microsurfaced Grafts in Deep Burn Wounds
RECRUITING · Phase 4
-
Comparison of Wound Bed Establishment in Facial Burns
COMPLETED · Phase 4
-
Suprathel® Use During Prolonged Field Care to Promote Healing and Reduce the Need for Grafting of Burn Wounds
RECRUITING · NA
-
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.